Syneron Medical Ltd. is a public company, that develops and markets aesthetic medical products. Its product line includes devices for hair removal, wrinkle treatment, and skin rejuvenation. Shares of Syneron are traded on the NASDAQ Global Select Market. Syneron Medical operates in the esthetic medical products industry, developing and manufacturing a range of electronic devices and associated products for use in nonsurgical cosmetic procedures, such as hair removal, wrinkle reduction and skin tightening. Among the companies with which Syneron competes are Lumenis, Zeltiq Aesthetics, Cutera, Solta Medical, Venus Concept, Cynosure, and Palomar Medical Technologies. Syneron Medical was founded in 2000 by Shimon Eckhouse (b. 1945), Technion alumnus and later UC Irvine graduate (Physics, Ph.D). In 2004 shares of Syneron began trading on the Nasdaq National Market. In 2007 Syneron entered into an exclusive cooperation agreement with Procter & Gamble, according to which Syneron develops and manufactures its products and Procter & Gamble markets and distributes them. In 2008 Syneron began expanding into the Chinese market, where its primary clients are hospitals and beauty clinics. Syneron capitalized on the 2009 global recession to acquire Massachusetts-headquartered light-based esthetic therapy company Candela Corporation.